(Reuters) – Advisers to the U.S. Food and Drug Administration on Tuesday recommended the authorization of Moderna Inc’s COVID-19 vaccine for children and teens aged 6 to 17 years of age. (Reporting by Manas Mishra in Bengaluru; Editing by Chris Reese)
Health
U.S. FDA advisers back authorization of Moderna COVID vaccine for ages 6-17
(Reuters) – Advisers to the U.S. Food and Drug Administration on Tuesday recommended the authorization of Moderna Inc’s COVID-19 vaccine for children and teens aged 6 to 17 years of age.
(Reporting by Manas Mishra in Bengaluru; Editing by Chris Reese)